University of Saskatchewan
University of Saskatchewan, International Vaccine Centre (InterVac)
Project Description
The $110 Million InterVac facility is a laboratory on the University of Saskatchewan campus. It was constructed by VIDO (Veterinary Infectious Diseases Organization). The Primary function of this facility is to test vaccines. This facility contains more than 10,000m2 of containment levels of CL2, CL3 and CL3 Ag space. Hemisphere provided mechanical and electrical consultant services for this high containment lab and completed commissioning activities for this facility in 2013. There is a worldwide shortage of facilities in which to study diseases such as avian influenza H5N1, tuberculosis, West Nile virus and SARS - all Containment Level 3 diseases. InterVac is the largest Containment Level 3 facility in Western Canada, developing vaccines for humans and animals against emerging or persistent CL3 diseases. InterVac enhances a life sciences research cluster that is unique in North America.
Awards:
- 2014 SCA Member Award Innovation in Action - Saskatchewan Construction Association